News Search Results
Aug 12, 2025, 16:05 ET Caris Life Sciences Reports Second Quarter 2025 Financial Results
709,261 Series B preferred stock, par value $0.001: no and 30,000,000 shares authorized as of June 30, 2025 and December 31,
More news about: Caris Life Sciences
Aug 12, 2025, 10:04 ET ketteQ Named One of Inc. Magazine's Fastest-Growing Private Companies
growth set them apart within their industries. The honor comes on the heels of ketteQ's recently announced $20 million Series B funding round, which will accelerate continued expansion, innovation, and customer success. ketteQ is reinventing supply chain planning
More news about: ketteQ Holdings Inc.
Aug 12, 2025, 09:17 ET Squint Raises $40M Series B to Expand Agentic Manufacturing and Accelerate Human Potential with AI
/PRNewswire/ -- Squint, the leading Manufacturing Intelligence Platform, today announced it has raised $40 million in Series B funding, bringing total funding to more than $59 million. This round was led by The Westly Group and TCV, with repeat
More news about: Squint
Aug 12, 2025, 09:00 ET Profound Raises $35M Series B as AI Search Becomes the Next Platform Shift
Series B led by Sequoia Capital accelerates Profound's evolution into the command center for modern marketing as brands race to control their AI presence NEW YORK,
More news about: Profound
Aug 12, 2025, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Second Quarter Results and Provides Business Update
exercise price of (i) series A warrants to purchase 61,538 shares of the Company's common stock at $65.00 per share (ii) series B warrants to purchase 27,400 shares of Common Stock at $65.00 per share (iii) series C warrants to purchase 66,667 shares
More news about: Acurx Pharmaceuticals, Inc.
Aug 12, 2025, 07:00 ET Broadridge Partners with BMLL to Bring Advanced Pre-Trade Analytics to Global Trading Participants
led by Optiver, with participation from CTC Venture Capital and existing investors. This follows BMLL's $26 million Series B investment from Nasdaq Ventures, FactSet, IQ Capital's Growth Fund and Snowflake Ventures in 2022/2023. Prior to that, BMLL raised $36m
More news about: Broadridge Financial Solutions, Inc.
Aug 11, 2025, 16:16 ET LivePerson Announces Deleveraging Transaction
(the "New Secured Notes"), (iii) shares of Series B Fixed Rate Convertible Perpetual Preferred Stock ("Series B Preferred Stock") and (iv) shares of the Company's common stock (the "Common Equity Shares," together with the New Secured Notes and the Series B Preferred Stock, the "New Securities") in an
More news about: LivePerson
Aug 11, 2025, 14:51 ET Softwear Automation Secures $20 Million in Series B1 Funding Round Led by Strategic Partnership with BESTSELLER
-- Softwear Automation, the pioneer in autonomous sewing technology, today announced the successful close of its $20 million Series B1 funding round, marking a major milestone in its mission to revolutionize sewn goods manufacturing. The round was led by a strategic investment from
More news about: SoftWear Automation, Inc.
Aug 11, 2025, 14:38 ET Softwear Automation Secures $20 Million in Series B1 Funding Round Led by Strategic Partnership with BESTSELLER
-- Softwear Automation, the pioneer in autonomous sewing technology, today announced the successful close of its $20 million Series B1 funding round, marking a major milestone in its mission to revolutionize sewn goods manufacturing. The round was led by a strategic investment from
More news about: SoftWear Automation, Inc.
Aug 07, 2025, 16:05 ET Identiv Reports Second Quarter 2025 Financial Results
(10,774) Cumulative dividends on Series B convertible preferred stock (205)
More news about: Identiv
Aug 07, 2025, 08:54 ET FORT Robotics Secures Additional $18.9 Million in Series B, Bringing Total Funding to $60.5 Million
Series B expansion fuels innovation in safety for robotics and physical AI PHILADELPHIA, Aug. 7, 2025 /PRNewswire/ -- FORT Robotics,
More news about: FORT Robotics
Aug 07, 2025, 08:54 ET FORT Robotics Secures Additional $18.9 Million in Series B, Bringing Total Funding to $60.5 Million
Series B expansion fuels innovation in safety for robotics and physical AI PHILADELPHIA, Aug. 7, 2025 /PRNewswire/ -- FORT Robotics,
More news about: FORT Robotics
Aug 07, 2025, 07:28 ET ARTBIO Appoints Four New Board Members, Co-Founder Transitions to Technical Advisory Board Role
Mr. Gelman holds a B.S.E. in Industrial Engineering from the University of Michigan."Following our recent Series B funding round, these appointments will enable ARTBIO to rapidly advance multiple programs designed to have the highest patient impact," said
More news about: ARTBIO
Aug 07, 2025, 06:30 ET Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
offering. The company may receive up to an aggregate of $130 million of additional proceeds if the Series A Warrants and Series B Warrants are exercised in full for cash. The financing was co-led by BVF Partners and Coastlands Capital, and included participation from Aberdeen
More news about: Immunic, Inc.
Aug 06, 2025, 09:00 ET Voxel Expands Global Reach and Leadership Bench to Power the Next Era of AI Safety
Series B funding round earlier this year, Voxel continues to invest in R&D, talent acquisition, and global expansion to meet surging market demand.
More news about: Voxel
Aug 06, 2025, 08:00 ET Unlock Expands Service to Homeowners, Adding Five States and New Leadership to Drive Growth
available in 24 states, representing a more than 40% increase over 2024. "This recent growth is part of the strategic roadmap we laid out for our Series B funding last year," said Jim Riccitelli, CEO of Unlock. "We're now the first provider to offer home equity agreements
More news about: Unlock Technologies
Aug 05, 2025, 16:39 ET Centrus Reports Second Quarter 2025 Results
— Series B Senior Preferred Stock, none issued —
More news about: Centrus Energy Corp.
Aug 05, 2025, 16:30 ET ASUR Announces Total Passenger Traffic for July 2025
Mexican Bolsa, where it trades under the symbol ASUR, and on the NYSE in the U.S., where it trades under the symbol ASR. One ADS represents ten (10) series B shares. For more information, visit
More news about: Grupo Aeroportuario del Sureste, S.A.B. de C.V.
Aug 05, 2025, 16:05 ET Lucid Announces Second Quarter 2025 Financial Results
Preferred stock 10,000,000 shares authorized as of June 30, 2025 and December 31, 2024, Series B redeemable convertible preferred stock, par value $0.0001; 75,000 shares issued and outstanding as of June 30, 2025 and
More news about: Lucid Group
Aug 05, 2025, 10:08 ET ketteQ Secures $20M Series B Funding to Scale Global Growth and Continued AI-Powered Supply Chain Planning Innovation
continue backing the team in this next phase of global growth." Learn MoreTo explore ketteQ's Series B funding, strategy, and future vision, visit the Series B landing page at
More news about: ketteQ Holdings Inc.
Aug 05, 2025, 09:00 ET Lyric Raises $43.5M Series B to Transform Supply Chain Decision Making with AI
leading AI-powered platform transforming supply chain decision making, today announced it has raised $43.5 million in Series B funding. The round was led by global software investor Insight Partners, with participation from Primary Venture Partners, Permanent Capital Ventures,
More news about: Lyric
Aug 04, 2025, 02:58 ET Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
ABT-301 while pursuing global licensing and strategic partnerships to accelerate commercialization and market entry. The company is also launching its Series B fundraising to attract strategic partners committed to advancing innovative cancer therapies and global expansion. About Anbogen Therapeutics
More news about: Anbogen Therapeutics
Aug 04, 2025, 02:29 ET Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
ABT-301 while pursuing global licensing and strategic partnerships to accelerate commercialization and market entry. The company is also launching its Series B fundraising to attract strategic partners committed to advancing innovative cancer therapies and global expansion. About Anbogen Therapeutics
More news about: Anbogen Therapeutics
Aug 01, 2025, 07:00 ET Enbridge Reports Record Second Quarter EBITDA, Reaffirms 2025 Financial Guidance and Announces Investments To Serve Growing Industrial, Power and LNG Demand
$0.34375 Preference Shares, Series B $0.32513
More news about: Enbridge Inc.
Aug 01, 2025, 06:42 ET Weekly Recap: 12 Tech Press Releases You Need to See
Arbital Health Secures $31M Series B to Scale Infrastructure for Value-Based Care Risk Contracting "Arbital Health has built something the healthcare industry desperately needs:
More news about: PR Newswire